Expert Guidance for Optimizing Immune Checkpoint Inhibitor Therapy for Kidney and Bladder Cancer

Event Overview

Location:
Rosen Shingle Creek
Sebastian I (1/2/3)
9939 Universal Blvd
Orlando, Florida
Join us for a CME-certified satellite meeting at ASCO GU 2017 on the latest data on the use of immune checkpoint inhibitors and corresponding guideline recommendations for the optimal care of patients with renal cell carcinoma and bladder cancer.

Not an official event of the 2017 Genitourinary Cancers Symposium. Not sponsored, endorsed, or accredited by ASCO or the Conquer Cancer Foundation.

Agenda

Agenda

Welcome and Program Overview


Clinical Rationale for Immunotherapy Approaches for Advanced Bladder and Kidney Cancer
Elizabeth R. Plimack, MD, MS (Program Director)


Clinical Development of Immune Checkpoint Inhibitors in Advanced Bladder Cancer
Timothy M. Kuzel, MD, FACP


Clinical Development of Immune Checkpoint Inhibitors in Advanced Renal Cell Carcinoma
M. Dror Michaelson, MD, PhD


Integrating Immune Checkpoint Inhibitors Into the Clinic
Elizabeth R. Plimack, MD, MS (Program Director)


Panel Discussion, Audience Question and Answer Session, and Concluding Remarks